Abstract:The dissolution rate of a crystalline solid dispersion could be influenced by multiple factors including its composition, the form and crystallinity of the containing drug, and its microstructure. In this study, crystalline dispersions of a fast-crystallizing drug, beta-lapachone (beta-LAP), within the matrix of polyethylene glycol (PEG) or poly(ethylene oxide) poly(propylene oxide) poly(ethylene oxide) triblock copolymer (Poloxamer 188), were obtained by spray drying. The drug polymer interaction, crystallization kinetics of the drug and polymer upon solvent evaporation, and the microstructure of the crystalline dispersion were investigated by various techniques including differential scanning calorimetry, polarized optical microscopy/hot-stage, scanning electron microscopy, wide-angle X-ray diffraction, small-angle X-ray scattering, atomic force microscopy, X-ray photoelectron spectroscopy, etc. The intrinsic dissolution rate of the beta-LAP/P188 crystalline dispersion was almost 30 times faster than that of beta-LAP/PEG, which was attributed to the difference in their crystalline microstructures, rather than any differences in their;drug crystal form, size, or crystallinity. During solvent evaporation, PEG crystallized first and beta-LAP molecules were uniformly restricted in the interlamellar or interfibrillar regions of PEG due to the strong beta-LAP/PEG interaction and then crystallized into perfect crystals that homogeneously distributed and densely packed within the PEG matrix. Such microstructure prevented a 'fast dissolution of beta-LAP/PEG dispersion. In comparison, beta-LAP crystallized simultaneously with P188 without being confined by a preformed crystalline microstructure of the polymer. The reciprocal crystallization inhibition between beta-LAP and P188 caused substantial defects in the beta-LAP crystals. At the same time, beta-LAP molecules were expelled to the interfibrillar region or to the growth front of P188 crystals, resulting in a heterogeneous drug distribution in the disordered and loosely packed microstructure. Such microstructure and crystalline defects of drug crystals synergistically facilitated the fast dissolution Of beta-LAP/P188 crystal dispersions. We conclude that molecular interaction between drug and polymer, as well as the crystallization kinetics of each component within the binary system, critically affect the microstructure and the dissolution, performance of crystalline solid dispersions.

Solid dispersion of β-lapachone in PVP K30 and PEG 6000 by spray drying technique

Dissolution Characteristics of Fast-Crystallizing Β-Lapachone Within Different Semicrystalline Microstructures of Polyethylene Glycol or Poly(ethylene Oxide)–poly(propylene Oxide)–poly(ethylene Oxide) Triblock Copolymer

Evaluation of Spironolactone Solid Dispersions Prepared by Co-Spray Drying With Soluplus® and Polyvinylpyrrolidone and Influence of Tableting on Drug Release

Physical Characterization of Lansoprazole/Pvp Solid Dispersion Prepared by Fluid-Bed Coating Technique

Comparative Study of Spray-Drying and Freeze-Drying Techniques for Increasing Fenofibrate’s Solubility and Dissolution Rate

Preparation, Characterization And In Vitro Release Properties Of Ibuprofen-Loaded Microspheres Based On Polylactide, Poly(Epsilon-Caprolactone) And Their Copolymers

Lysosome-oriented, dual-stage pH-responsive polymeric micelles for β-Lapachone delivery

Prodrug Strategy to Achieve Lyophilizable, High Drug Loading Micelle Formulations Through Diester Derivatives of Β‐lapachone

Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(ε-caprolactone) and their copolymers

Lysosome-Oriented, Dual-Stage Ph-Responsive Polymeric Micelles For Beta-Lapachone Delivery

Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment

Co-Spray Drying of Paracetamol and Propyphenazone with Polymeric Binders for Enabling Compaction and Stability Improvement in a Combination Tablet

Oral Bioavailability Enhancement of Β-Lapachone, a Poorly Soluble Fast Crystallizer, by Cocrystal, Amorphous Solid Dispersion, and Crystalline Solid Dispersion.

Investigating the influence of protein secondary structure on the dissolution behavior of β-lactoglobulin-based amorphous solid dispersions

Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions

Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000

Formulation, Development, Evaluation and Solubility Enhancement of Lercanidipine Hydrochloride by Solid Dispersion Techniques

Formulation and characterization of glipizide solid dosage form with enhanced solubility

Sustained release biodegradable solid lipid microparticles: Formulation, evaluation and statistical optimization by response surface methodology

Investigating the effect of polyvinylpyrrolidone matrix on surface characteristics and dissolution rate of anticancer drug dasatinib

Comparison of three different types of cilostazol-loaded solid dispersion: Physicochemical characterization and pharmacokinetics in rats